Niraparib in Patients With Pancreatic Cancer

NCT03601923 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Niraparib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]